Classification of Aurora‐A Kinase Inhibitors Using Self‐Organizing Map (SOM) and Support Vector Machine (SVM)
暂无分享,去创建一个
[1] J. Bischoff,et al. The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. , 1999, Trends in cell biology.
[2] H. Hsieh,et al. Aurora kinase A inhibitors: identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffold. , 2008, Bioorganic & medicinal chemistry letters.
[3] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[4] J. Gasteiger,et al. ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .
[5] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[6] Mohane Selvaraj Coumar,et al. Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificity. , 2009, Journal of medicinal chemistry.
[7] J. Pollard,et al. Discovery and development of aurora kinase inhibitors as anticancer agents. , 2009, Journal of medicinal chemistry.
[8] Johann Gasteiger,et al. A new model for calculating atomic charges in molecules , 1978 .
[9] Bernhard Schölkopf,et al. Comparing support vector machines with Gaussian kernels to radial basis function classifiers , 1997, IEEE Trans. Signal Process..
[10] Mladen Vinković,et al. Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity. , 2009, Journal of medicinal chemistry.
[11] Wang Shen,et al. Discovery of a potent and selective aurora kinase inhibitor. , 2008, Bioorganic & medicinal chemistry letters.
[12] J. Breed,et al. SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors. , 2006, Bioorganic & medicinal chemistry letters.
[13] B. Fan,et al. Classification of estrogen receptor-beta ligands on the basis of their binding affinities using support vector machine and linear discriminant analysis. , 2008, European journal of medicinal chemistry.
[14] Kenneth J. Miller,et al. Additivity methods in molecular polarizability , 1990 .
[15] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[16] D. McRee,et al. Structural basis for the inhibition of Aurora A kinase by a novel class of high affinity disubstituted pyrimidine inhibitors. , 2006, Bioorganic & medicinal chemistry letters.
[17] Teuvo Kohonen,et al. Self-organized formation of topologically correct feature maps , 2004, Biological Cybernetics.
[18] Johann Gasteiger,et al. QUANTITATIVE MODELS OF GAS-PHASE PROTON-TRANSFER REACTIONS INVOLVING ALCOHOLS, ETHERS, AND THEIR THIO ANALOGS. CORRELATION ANALYSES BASED ON RESIDUAL ELECTRONEGATIVITY AND EFFECTIVE POLARIZABILITY , 1984 .
[19] Guy Georges,et al. A pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailability. , 2008, Journal of medicinal chemistry.
[20] V. Vapnik,et al. Bounds on Error Expectation for Support Vector Machines , 2000, Neural Computation.
[21] J. Gasteiger,et al. FROM ATOMS AND BONDS TO THREE-DIMENSIONAL ATOMIC COORDINATES : AUTOMATIC MODEL BUILDERS , 1993 .
[22] J. Gasteiger,et al. Autocorrelation of Molecular Surface Properties for Modeling Corticosteroid Binding Globulin and Cytosolic Ah Receptor Activity by Neural Networks , 1995 .
[23] S. Sen,et al. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines , 1997, Oncogene.
[24] J. Xu,et al. Development and Biological Evaluation of a Novel Aurora A Kinase Inhibitor , 2009, Chembiochem : a European journal of chemical biology.
[25] G. Schneider,et al. Scaffold‐Hopping Potential of Ligand‐Based Similarity Concepts , 2006, ChemMedChem.
[26] Jennafer Dotson,et al. A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B. , 2009, Journal of medicinal chemistry.
[27] H. Koblish,et al. The synthesis and SAR of 2-amino-pyrrolo[2,3-d]pyrimidines: a new class of Aurora-A kinase inhibitors. , 2006, Bioorganic & medicinal chemistry letters.
[28] Binne Zwanenburg,et al. A two-step chirality transfer from (−)-endo- to (−)-exo-tricyclo[5.2.1.026]deca-4,8-dien-3-one , 1993 .
[29] Johann Gasteiger,et al. Similarity Perception of Reactions Catalyzed by Oxidoreductases and Hydrolases Using Different Classification Methods , 2010, J. Chem. Inf. Model..
[30] T. Kohonen. Self-organized formation of topographically correct feature maps , 1982 .
[31] Johann Gasteiger,et al. Self-organizing maps for identification of new inhibitors of P-glycoprotein. , 2007, Journal of medicinal chemistry.
[32] Michel Petitjean,et al. Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds , 1992, J. Chem. Inf. Comput. Sci..
[33] Brian Schryver,et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers , 1998, The EMBO journal.
[34] F. Pavone,et al. Novel carbazole derivatives as NPY Y1 antagonists. , 2007, Bioorganic & medicinal chemistry letters.
[35] Johann Gasteiger,et al. Mining High-Throughput Screening Data of Combinatorial Libraries: Development of a Filter to Distinguish Hits from Nonhits , 2004, J. Chem. Inf. Model..
[36] Teuvo Kohonen,et al. Self-Organization and Associative Memory, Third Edition , 1989, Springer Series in Information Sciences.
[37] H. Mori,et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. , 1999, Cancer research.
[38] Paola Storici,et al. 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile. , 2006, Journal of medicinal chemistry.
[39] M. Dimopoulos,et al. Aurora kinases as targets for cancer therapy. , 2008, Cancer treatment reviews.